Active Ingredient(s): Bezlotoxumab
FDA Approved: * October 21, 2016
Pharm Company: * MERCK SHARP DOHME
Category: Immune System

Bezlotoxumab, sold under the brand name Zinplava, is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infections.[1] This drug, along with actoxumab, was developed through Phase II efficacy trials by a partnership between Medarex Inc and MassBiologics of the University of Massachusetts Medical School.[2] The project was then licensed to Merck Sharp & Dohme Corp for further development and commercialization.&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Zinplava 25 mg/ml Intravenous Injection, Solution
NDC: 0006-3025
Merck Sharp & Dohme Corp.

Popular Topics

Side effects from Zinplava

I was given this drug 2 days ago for c diff that I've been battling for 5 months. I feel like I've been hit by a...